Article Details
Retrieved on: 2025-02-17 14:24:50
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article discusses advancements in the Atherosclerotic Cardiovascular Disease (ASCVD) market, emphasizing epidemiology and novel treatments like PCSK9 inhibitors, Inclisiran, and statins. The text highlights increased market growth driven by new therapies and diagnostic tools, while the key concept and tags focus on cardiology, lipid management, and therapeutic innovations by IMARC Group.
Article found on: www.biospace.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here